Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edelman

Showing results (161-170 of 348) with videos related to

Pageof 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A ReviewVictor E Chen, Benjamin A Greenberger, James M Taylor, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2009
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancerMartin J Edelman, Whitney Burrows, Mark J Krasna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I and pharmacokinetic study of 7-hydroxystaurosporine and carboplatin in advanced solid tumorsMartin J Edelman, Kenneth S Bauer, Suhlan Wu, et al.
International Journal of Cancer|May 18, 2010
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cellsMinu K Srivastava, Jacobus J Bosch, Ashley L Wilson, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2017
Daily diary study of hope, stigma, and functioning in lung cancer patientsLaurie E Steffen, Kevin E Vowles, Bruce W Smith, et al.
Frontiers in Neuroscience|April 24, 2018
A Study of the Effects of Electrode Number and Decoding Algorithm on Online EEG-Based BCI Behavioral PerformanceJianjun Meng, Bradley J Edelman, Jaron Olsoe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Cancer Genomics & Proteomics|September 20, 2007
Cancer stem cells and individualized therapySaranya Chumsri, Pornima Phatak, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Pageof 35

Showing results (161-170 of 348) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A ReviewVictor E Chen, Benjamin A Greenberger, James M Taylor, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Lung Cancer (Amsterdam, Netherlands)|June 23, 2009
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancerMartin J Edelman, Whitney Burrows, Mark J Krasna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I and pharmacokinetic study of 7-hydroxystaurosporine and carboplatin in advanced solid tumorsMartin J Edelman, Kenneth S Bauer, Suhlan Wu, et al.
International Journal of Cancer|May 18, 2010
MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cellsMinu K Srivastava, Jacobus J Bosch, Ashley L Wilson, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2017
Daily diary study of hope, stigma, and functioning in lung cancer patientsLaurie E Steffen, Kevin E Vowles, Bruce W Smith, et al.
Frontiers in Neuroscience|April 24, 2018
A Study of the Effects of Electrode Number and Decoding Algorithm on Online EEG-Based BCI Behavioral PerformanceJianjun Meng, Bradley J Edelman, Jaron Olsoe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304Martin J Edelman, Lydia Hodgson, Xiaofei Wang, et al.
Cancer Genomics & Proteomics|September 20, 2007
Cancer stem cells and individualized therapySaranya Chumsri, Pornima Phatak, Martin J Edelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2009
Targeted radiopharmaceutical therapy for advanced lung cancer: phase I trial of rhenium Re188 P2045, a somatostatin analogMartin J Edelman, Gerry Clamon, Daniel Kahn, et al.
Pageof 35